Treatment of buccal mucosal carcinomas: A survey amongst head and neck surgeons in the Netherlands.

ABSTRACT:

Objective

Currently, there is no up-to-date guideline for the treatment of buccal mucosal squamous cell carcinoma (BMSCC) in the Netherlands. A questionnaire was used to investigate the opinions of Dutch head and neck surgeons on BMSCC of the cheek treatment.

Methods

A questionnaire was sent to all 91 head and neck surgeons in the Netherlands. Their opinions on surgical tumor-free margins, through-and-through defects, and indications for local adjuvant therapy were questioned.

Results

The response rate was 51%. To prevent a through-and-through defect, 67% of the surgeons would accept a deep clinical (macroscopic) margin of ≤5 mm. The less adverse histological characteristics a tumor has, the less consensus there is amongst the surgeons for local adjuvant treatment in

SUBMITTER: Adriaansens CMEM 

PROVIDER: S-EPMC10446276 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature